X leflunomide powder

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

LEFLUNOMIDE (UNII: G162GK9U4W) (LEFLUNOMIDE - UNII:G162GK9U4W)

Disponible depuis:

AX Pharmaceutical Corp

DCI (Dénomination commune internationale):

LEFLUNOMIDE

Composition:

LEFLUNOMIDE 99 g in 100 g

Statut de autorisation:

Bulk Ingredient For Animal Drug Compounding

Résumé des caractéristiques du produit

X - LEFLUNOMIDE POWDER
AX PHARMACEUTICAL CORP
----------
X
AX Pharmaceutical Corp
leflunomide powder
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-0 8 3
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
LEFLUNO MIDE (UNII: G16 2GK9 U4W) (LEFLUNOMIDE - UNII:G16 2GK9 U4W)
LEFLUNOMIDE
9 9 g in 10 0 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PRODUCT CHARACTERISTICS
COLOR
white (white)
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-0 8 3-0 1
10 0 g in 1 BOTTLE
0 5/22/20 15
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
BULK INGREDIENT FOR ANIMAL DRUG
COMPOUNDING
0 5/22/20 15
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
AX Pharmaceutical Co rp
20 29 248 58
repack(6 2157-0 8 3) , relabel(6 2157-0 8 3)
Revised: 5/2016